Position in NBIX
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$4,625,748
+$996,443 QoQ
Shares Held
27,446
-0.4% QoQ
Ownership
0.027%
of shares outstanding
% of Portfolio
0.56%
of 13F equity value
Holder Rank
#220
of 772 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Stanley-Laman Group, Ltd. holds $12,165,674 across 2 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (38.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LNTH |
Lantheus Holdings, Inc.
|
67,964 | $7,539,926 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
This page
|
27,446 | $4,625,748 |
All Filings in NBIX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,625,748 | 27,446 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $3,629,305 | 27,549 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $3,917,060 | 27,618 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $3,559,194 | 25,354 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $5,344,464 | 42,521 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $3,612,085 | 32,659 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $5,754,567 | 42,158 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $4,324,321 | 37,531 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $3,778,077 | 27,443 | Shares | Sole | 2024-07-18 | |
| No filing history on record for this holder in this stock. | ||||||